ArticlePilot and feasibility studies2025
Protocol for a pilot study to assess the feasibility of interrupting prolonged sitting in the evening with activity breaks in a group of free-living adults.
Article in Pilot and feasibility studies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An Evening Activity Breaks Intervention for Improvement of Glucose, Blood Pressure, and Sleep: A Pilot Study in Free-Living Adults.Diabetes, obesity & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundGreater time spent sedentary, particularly when accumulated in long, uninterrupted bouts, is associated with poorer cardiometabolic health and an increased risk of disease incidence and mortality. Experimental studies have indicated that regularly interrupting sedentary time during the day, and more recently, in the evening, with acute (2-5 min) bouts of activity improves postprandial metabolism in a range of adult populations. The effects of interrupting evening sitting time have yet to be explored in a free-living setting. Drawing on the Behaviour Change Wheel and participant-identified barriers and facilitators, the regular activity breaks (RAB) intervention was designed to support participants in interrupting evening prolonged sitting. This pilot and feasibility study will explore the feasibility of this intervention and its effects on 24-h movement patterns, glycemic control, and blood pressure. Results from this study will inform the development of a future effectiveness trial.
methodsThis 4-week, single-group intervention trial consists of a baseline, a 2-week intervention, and a 2-week follow-up period. A total of 20 adults, ≥ 18 years who self-report habitually sitting for at least 3 h in the evening, have a smartphone, and can ambulate unaided will be recruited to participate. The RAB intervention aims to support participants to regularly (~ every 30 min) perform short bouts (2-3 min) of activity during periods of prolonged sitting in the evening. The intervention components include (1) a structured consultation with the study coach where behaviour change techniques will be used to create an individualised plan for performing activity breaks in the evening; (2) provision of a mobile application to provide scheduled reminders and activity break videos; and (3) follow-up support in the form of phone calls performed on days 3 and 7. Feasibility will be assessed by meeting recruitment and retention targets; the acceptability of the intervention will be assessed via semi-structured interviews. Pilot outcomes include the number of activity breaks performed, impact on 24-h movement patterns (sleep duration and quality, sedentary time, and physical activity), blood pressure, interstitial glycemic response, mobile application engagement and capability, and opportunity and motivation to change evening sitting behaviour. DISCUSSION: Should the RAB intervention meet the criteria to be deemed feasible and acceptable, this will provide justification and information for its use in a large-scale effectiveness trial.
trial registrationThis study is registered with the Australian New Zealand Clinical Trials Registry (ANZCTR 12624000371594). Registered March 28, 2024.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.